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Advanced glycation end products (AGEs) as well as advanced lipoxidation end products (ALEs) are prooxidant and proinflammatory compounds that have recently been linked to impaired insulin sensitivity (8) . These compounds continuously form in the body from the reaction of reducing sugars and reactive carbonyls with free amino groups (9), while amine-containing lipids are also generators of lipid peroxidation products (10 -12) . AGEs/ ALEs can also originate exogenously, during heat processing of food (13) (14) (15) (16) , and become incorporated in body components after intestinal absorption (17) . It has now become apparent that dietary AGEs represent a significant source of circulating and tissue AGEs, manifesting similar pathogenic properties to their endogenous counterparts (17) (18) (19) (20) (21) (22) (23) (24) . The restriction of the AGE content in standard mouse diets was found, among other effects, to markedly improve insulin resistance in obese db/db (ϩϩ) mice (8) . Because fat-rich foods are also particularly rich in AGEs/ALEs (16), we postulated that the insulin resistance observed after chronic high-fat feeding (25) is related to the obligatory intake of large amounts of AGEs inherent in these diets. To test this hypothesis, we evaluated glucose and insulin responses, visceral adiposity, pancreatic islet morphology, and type 2 diabetes incidence in mice subjected to long-term feeding on high-fat diets but with either high or low AGE/ALE content. We also measured plasma 8-isoprostane as an index of systemic oxidant stress and plasma adiponectin as a molecule that has been found to be inversely correlated with insulin resistance. urine samples were obtained, and mice were randomly assigned for 6 months to one of two isocaloric high-fat diets (35% g fat, PicoLab Rodent Diet D12492) (Labdiet; Purina Mills, St. Louis, MO): one with high AGE content (HAGE-HF group; 6.8-fold higher than the regular diet, obtained by heating at 120°C ϫ 30 min) and the other with 2.4-fold lower AGE content (LAGE-HF group) than the HAGE-HF group (Table 1) . Age-and sex-matched C57/BL6 mice and, for certain studies, db/db (ϩϩ) mice (n ϭ 10) were placed on regular diet (PicoLab Rodent Diet D12450B; Labdiet; Purina Mills; 5% g fat, 117 units/mg AGE) and used as controls. Body weight and food intake (in grams of food per mouse) were monitored daily for 1 week and weekly thereafter throughout the duration of the study. Fasting blood glucose was monitored weekly. All procedures were approved by the institutional animal care and use committee. Assays. Food, serum, and visceral fat AGEs were measured by enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (4G9; Alteon, Ramsey, NJ), as previously described (26) . This antibody is highly reactive with ⑀N-carboxymethyllysine, an established biomarker for protein-and lipid-derived AGEs (27) . Serum adiponectin and plasma 8-isoprostane levels were measured by ELISA using a mouse/rat adiponectin kit (Alpco Diagnostics, Windham, NH) and 8-isoprostane competitive enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI), respectively. Blood glucose was determined with an Elite Glucometer (Bayer, Mishawaka, IN). Serum insulin levels were measured with an ultra-sensitive rat insulin ELISA kit (Alpco Diagnostics) using rat standards (100% cross-reactivity with mouse insulin). Plasma lipid profile was determined at baseline and at week 22. Plasma samples were fractionated by two sequential steps of ultracentrifugation using a Beckman TLA-100 rotor at 70,000 rpm for 3 h at 4°C, followed by centrifugation with KBr (1.12 density) at 70,000 rpm overnight at 4°C. After the second centrifugation, the lower sample fraction was used for HDL determination. Total plasma and HDL cholesterol were determined using an infinity cholesterol reagent colorimetric assay kit (Sigma Diagnostics, St. Louis, MO). Serum triglycerides were measured using the GPO-Trinder colorimetric assay kit (Sigma Diagnostics) (8) . Glucose tolerance test and glycemic clamps. After 23 weeks on their respective diets, an intravenous glucose tolerance test was performed on all groups (n ϭ 5 per group) by tail vein injection of glucose (1 g/kg) after an overnight fast (13-15 h ). Blood samples for glucose testing were taken before glucose injection and at several intervals for a total of 120 min.
Following the period of exposure to the diets, euglycemic and hyperglycemic clamps were performed on all groups (n ϭ 5 per group) (28, 29) . Three days before the testing, mice were anesthetized with intraperitoneal injection of ketamine and xylazin cocktail solution, and a catheter was inserted in the right jugular vein and externalized through an incision in a skin flap behind the head (28, 29) . Thus, studies were performed in awake, unstressed, chronically catheterized animals.
For the euglycemic clamp, insulin was infused continuously at 18 mU ⅐ kg
Ϫ1
⅐ min Ϫ1 , while adjusting the rate of 10% glucose infusion to maintain plasma glucose levels steady at ϳ90 -100 mg/dl. Whole-body glucose disposal rate (equal to the amount of glucose infused in mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was calculated during the last 60 min of the clamp. Since endogenous glucose production is negligible under such an hyperinsulinemic state, the amount of glucose infused is considered equivalent to whole-body glucose disposal. For the hyperglycemic clamp, glucose levels were maintained at 300 -320 mg/dl for 1 h under different adjusted rates of glucose infusion. Histological analysis. After the animals were killed at the end of the study, visceral fat was separated, weighed, and stored at Ϫ80°C. Pancreatic samples were removed and fixed overnight in 10% formalin. Fixed tissues were processed for paraffin embedding. Sections were cut at a thickness of 4 m, mounted on glass slides, and stained with hematoxylin and eosin. For detection of insulin, 10 consecutive paraffin-embedded sections of pancreas were stained with a guinea pig polyclonal anti-swine insulin antibody (Dako, Carpinteria, CA). Glucagon staining was performed using rabbit anti-glucagon antibody (Research Diagnostics, Flanders, NJ). Statistical analysis. Data are presented as means Ϯ SE. Differences of means were analyzed by Student's t test or ANOVA, followed by the Bonferroni correction, depending of the number of groups. Statistically significant difference was defined as a P value Ͻ0.05. All reported P values are based on two-sided tests. All data analyses were performed using the GraphPad Prism statistical program (GraphPad Software, San Diego, CA).
RESULTS
Effect of diets on body weight, circulating AGEs, and fasting glucose, plasma insulin, and lipid levels. Daily food consumption by both high-fat groups was identical for the 1st week and remained similar throughout the study (6 g/day vs. 5.5 g/day for control mice).
At the end of the study, both groups fed the high-fat diet had gained more weight than the controls (P Ͻ 0.001), while the HAGE-HF group weighed only slightly more than the LAGE-HF mice (P Ͻ 0.01) ( Table 2 ). During the course of the study, serum AGE levels increased nearly threefold above baseline in the HAGE-HF group (P Ͻ 0.001), while in the LAGE-HF and control mice they rose by 2-and Data are means Ϯ SE. *Statistically significant difference between baseline and end of study within each group. †Statistically significant difference between each group and control mice at the end of study. ‡Statistically significant difference between the HAGE-HF and LAGE-HF groups at the end of study.
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1.6-fold (P Ͻ 0.01), respectively ( Table 2 ). Levels of triglycerides and total cholesterol increased significantly from baseline in both groups fed the high-fat diet, while HDL cholesterol remained unchanged (Table 2) . Interestingly, plasma insulin levels in the HAGE-HF group increased by 7.5-fold above baseline (P Ͻ 0.0001), but in the LAGE-HF group, these remained unchanged and similar to the control mice (Fig. 1B) . A similar trend was observed with fasting blood glucose levels (Fig. 1A) . Effect of diet on glucose tolerance tests and glycemic clamps. HAGE-HF mice displayed impaired glucose response closely resembling that of db/db mice during glucose tolerance tests, which was markedly different from the LAGE-HF (P Ͻ 0.02) and control groups (P Ͻ 0.01). In contrast, the glucose tolerance test profiles of the LAGE-HF group closely paralleled those of the control mice ( Fig. 2A) . During euglycemic clamps, glucose infusion rate in the HAGE-HF mice was as low as 50% that of the control mice (P Ͻ 0.001). In contrast, in the LAGE-HF group, glucose infusion rate showed no significant difference from the control group but differed significantly from the glucose infusion rate of both the HAGE-HF (P Ͻ 0.001) and the db/db (P Ͻ 0.001) groups (Fig. 2B) . During hyperglycemic clamps, plasma insulin in HAGE-HF mice reached levels approximately threefold higher than those of control mice (P Ͻ 0.001), while in LAGE-HF mice, despite a similar body weight gain and dietary fat intake, plasma insulin remained close to the control levels (P ϭ NS) (Fig. 2C) . Effect of diet on visceral fat, fat-AGE content, and circulating 8-isoprostane and adiponectin levels. As expected, significant differences were observed in total visceral fat content between the two high-fat-fed groups and the regular diet-fed controls (Fig. 3A) . Of note, however, the LAGE-HF group exhibited a significantly lower (ϳ50%) amount of visceral fat compared with that found in HAGE-HF mice (P Ͻ 0.001) (Fig. 3A) . In addition, the amount of AGE-modified fat per gram of fat associated with the LAGE-HF group was significantly smaller compared with that of HAGE-HF mice (P Ͻ 0.001) (Fig. 3B) . Consequently, the estimated amount of total AGE content present in visceral fat in the LAGE-HF mice was fourfold lower than that in the HAGE-HF mice (P ϭ 0.000).
At the end of the study, plasma 8-isoprostane levels, a measurement of systemic oxidant stress, were significantly elevated in the HAGE-HF and the db/db groups compared with the controls (P Ͻ 0.01). In the LAGE-HF group, 8-isoprostane levels were more modestly elevated above the control (P Ͻ 0.05) (Fig. 4A) .
As in the db/db (ϩϩ) mice, serum adiponectin levels were found markedly suppressed in the HAGE-HF group compared with controls (P Ͻ 0.001), while in the LAGE-HF group, these were reduced by only 25% compared with controls (P Ͻ 0.05) (Fig. 4B) . Effect of diet on islet morphology. Consistent with previous evidence based on the use of high-fat diets, pancreatic islets from the HAGE-HF mice after 6 months exhibited hyperplasia and hypertrophy combined with loss of islet structure and cellular homogeneity. However, such changes were only seen infrequently in islets from LAGE-HF mice ( Fig. 5A and B) . Instead, in the latter group, islet size appeared normal and well organized, with normal architecture and abundance of insulin-and glucagoncontaining cells. In addition, islet degeneration and insulin-and glucagon-producing cell displacement from the periphery to the center of the islets were only evident in islets from the HAGE-HF and not the LAGE-HF mice.
DISCUSSION
The studies presented demonstrate that in normal mice exposed to a high-fat diet, the metabolic changes, which lead to weight gain, glucose intolerance, insulin resistance, and type 2 diabetes are linked to the AGEs/ALEs present in the diet. In addition, the studies illustrate that visceral adiposity and systemic indicators of oxidative stress or inflammation, such as 8-isoprostane and adiponectin, can be differentially linked to the ingested AGEs beyond the excess of fat. Furthermore, pancreatic islet structure and function, which are affected negatively during prolonged exposure to a fat-rich diet, appear to be linked to the dietary content of glycoxidants and can thus be spared by a diet comparatively low in AGEs, even if it is fat rich.
These observations differ significantly from previous observations on the role of dietary AGEs in genetically type 2 diabetes-prone mice (8), the key difference here being the induction of insulin resistance and type 2 diabetes in normal mice exposed to excess fat, a dietary condition resembling that of many healthy humans.
In the present studies, high dietary fat intake by normal mice for the period between 1 and 7 months of age led to an increase in body weight of both high-and low-AGE groups, which was modest yet significantly higher in the HAGE-HF than in the LAGE-HF mice. Interestingly, a major proportion (ϳ75%) of the mice fed a HAGE-HF diet were diabetic by the end of the study compared with none of those exposed to the LAGE-HF diet, based on a fasting blood glucose level Ͼ130 mg/dl. The AGE-rich fatty diet resulted in a pattern of profound abnormalities in glucose tolerance, glucose disposal rate, and insulin responses closely resembling those of the diabetic db/db (ϩϩ) mice (8) . In contrast, exposure to the low-AGE fatty diet led to a pattern comparable with the normal metabolic profile associated with the standard (low-fat) diet. These findings suggest that dietary factors other than high fat content contribute to these metabolic changes.
Consistent with previous studies (8,18 -24) and given the equal exposure to basic nutrients and energy provided by the two high-fat diets, the present evidence points to the different content in dietary AGEs/ALEs as the probable contributors to the metabolic effects described. As expected, both high-fat formulas (35% fat) contained greater ⑀N-carboxymethyllysine-immuno-epitopes than did the standard diet (4.5% fat), consistent with the fact that lipid-rich food products, often rich in amino-lipids, especially phospholipids, provide an extra source of reactants for the complex series of reactions leading to the formation of AGEs/ALEs (11, 12, 27) as well as of oxidized fatty acids, which further enhance the formation of AGEs/ALEs (30) . Furthermore, the significant variance in AGE content between the HAGE-HF and LAGE-HF diets is attributable to the AGE-promoting methods and conditions used, e.g., exposure to elevated temperature and not to differences in nutrient composition (8, 16) . This was also clearly reflected in the higher circulating AGE levels in the HAGE-HF mice, relative to the other groups.
The identity of the AGE/ALE species responsible for the metabolic effects described remains speculative given the heterogeneity of these compounds. ⑀N-carboxymethyllysine, a chemically defined derivative of both glycoxidation and lipid peroxidation (27) , however, is thought to contribute to oxidative stress and tissue damage and has proved a useful indicator of AGEs, correlating well with diabetes and aging (9, 10, 31) as well as with a range of diet-induced pathological conditions (18 -22) .
Of particular interest in these studies was the differential accumulation of visceral fat in the HAGE-HF group compared with the LAGE-HF mice, despite similar dietary fat intake and body weight gain by both groups. Of further interest was the marked accumulation of total AGEs/ALEs in the visceral fat of the HAGE-HF group, reaching the total of fourfold more than that of the LAGE-HF group. This novel finding reveals a potentially important relationship between diet-related glycoxidant and lipoxidant substances and visceral adiposity, a risk factor associated with insulin resistance and the metabolic syndrome (32, 33) .
Visceral adipose tissue expansion has been associated with increased production of inflammatory mediators, such as tumor necrosis factor-␣ (34). Greater binding of AGE by proinflammatory AGE receptors, such as RAGE, could trigger oxidative stress and the release of cytokines such as tumor necrosis factor-␣ (35, 36) , which is known to inhibit insulin action (37) . This and a host of autocrine/ paracrine inflammatory molecules released from adipose tissue or macrophages, migrating to AGE-rich visceral fat, could contribute to the insulin resistance exhibited by HAGE-HF mice but yet not seen in the LAGE-HF mice, most likely related to the lower amount of AGE fat in the latter group.
The histology of the pancreatic islets from both experimental groups reflected a similar pattern. Nearly normal glucose and insulin responses seen in the LAGE-HF group were consistent with well-preserved pancreatic islet morphology and function in this group and contrasted with islet enlargement, structure disorganization, and sparsity of insulin production displayed by the HAGE-HF mice. The near-normal appearance of islets from the LAGE-HF mice together with the metabolic findings strongly suggest a protective role for a low-AGE diet, even if the fat content is elevated. The islet changes were consistent with those seen in db/db mice fed high-versus low-AGE diets (8) and offered further in vivo support to reports associating glycoxidation with inhibition of insulin gene transcription (38) or promotion of ␤-cell apoptosis in vitro (39) . Thus, given the significant prooxidant and proinflammatory properties of AGEs/ALEs exhibited in the absence of chronic hyperglycemia, diet-derived AGEs/ALEs may represent diabetogenic substances worthy of further rigorous evaluation.
The significant rise in plasma 8-isoprostanes in the high-fat-fed groups, a finding consistent with a state of increased oxidant stress (40) , may have also been the result of the higher supply of AGEs/ALEs in their diet (11) .
In agreement with this, adiponectin, a factor thought to play a role in regulating insulin sensitivity and to exert anti-inflammatory effects at large (41) , correlated inversely with 8-isoprostane and with visceral adiposity and remained significantly higher only in the LAGE fat-fed mice. These findings reveal new aspects of the balance between prooxidant AGEs/ALEs and anti-inflammatory innate defense mechanisms. The positive relationship between ingested and circulating AGE levels found in the present studies has been previously also linked to acute-phase proteins (C-reactive protein) and vascular dysfunction (23, 42) . These properties are herein expanded to include manifestations of insulin resistance and are exemplified in the context of a diet high in fat. Thus, dietary AGE, forming at high rates in the presence of excess fat and commonly applied levels of temperature, may independently contribute to the subinflammatory state associated with insulin resistance and metabolic syndrome in humans as well. To date, AGEs/ALEs are the only food-derived compounds studied for their contribution to diabetic tissue toxicity, including insulin-producing cells (8) . No other class of heat-enhanced substances has been studied for the intriguing array of cell effects exhibited by these substances, i.e., oxidant stress, nuclear facror-kB activation, cytokine (tumor necrosis factor-␣) induction, inflammation, and apoptosis (15, 36) .
In summary, during prolonged high-fat feeding, the AGE/ALE content of food may exert significant influence on the regulation of insulin secretion and action and visceral adiposity and may ultimately lead to type 2 diabetes. These results, taken together with previous work (8) on the effects of a high-in-AGE-but-low-in-fat diet on insulin resistance support the view that in addition to the fat, the high AGE/ALE content of food is significantly linked to the insulin-resistant state. While the mechanisms linking AGEs and the related deleterious metabolic effects are likely to be complex, the evidence indicates that lowering AGE/ALE content in fatty foods might be an intervention to control insulin resistance and prevent diabetes. Further long-term studies in humans are needed.
